These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37573219)

  • 1. Response to letter entitled: Re: Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study.
    Baltussen JC; Lemij AA; de Glas NA; Portielje JEA; Liefers GJ
    Eur J Cancer; 2023 Sep; 191():113240. PubMed ID: 37573219
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter Re: Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study.
    Chen H; Feng L
    Eur J Cancer; 2023 Sep; 191():113239. PubMed ID: 37550125
    [No Abstract]   [Full Text] [Related]  

  • 3. Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.
    Underwood EA; Jerzak KJ; Lebovic G; Rochon PA; Elser C; Pritchard KI; Tierney MC
    Support Care Cancer; 2019 Aug; 27(8):3035-3043. PubMed ID: 30610433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study.
    Baltussen JC; Derks MGM; Lemij AA; de Glas NA; Fiocco M; Linthorst-Niers EMH; Vulink AJE; van Gerven L; Guicherit OR; van Dalen T; Merkus JWS; Lans TE; van der Pol CC; Mooijaart SP; Portielje JEA; Liefers GJ
    Eur J Cancer; 2023 May; 185():1-10. PubMed ID: 36933518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx.
    Wagner LI; Gray RJ; Sparano JA; Whelan TJ; Garcia SF; Yanez B; Tevaarwerk AJ; Carlos RC; Albain KS; Olson JA; Goetz MP; Pritchard KI; Hayes DF; Geyer CE; Dees EC; McCaskill-Stevens WJ; Minasian LM; Sledge GW; Cella D
    J Clin Oncol; 2020 Jun; 38(17):1875-1886. PubMed ID: 32271671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies.
    Lee PE; Tierney MC; Wu W; Pritchard KI; Rochon PA
    Breast Cancer Res Treat; 2016 Aug; 158(3):407-20. PubMed ID: 27432418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of the executive attention network in premenopausal women with hormone receptor-positive breast cancer treated with tamoxifen.
    Chen X; Li J; Zhang J; He X; Zhu C; Zhang L; Hu X; Wang K
    Psychoneuroendocrinology; 2017 Jan; 75():116-123. PubMed ID: 27815995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.
    Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
    Psychooncology; 2012 May; 21(5):479-87. PubMed ID: 21351188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone Therapy Linked to Cognitive Decline.
    Cancer Discov; 2020 Jul; 10(7):896. PubMed ID: 32404306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
    Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
    J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tamoxifen and exemestane on cognitive function in postmenopausal patients with breast cancer.
    Lee Meeuw Kjoe PR; Kieffer JM; Small BJ; Boogerd W; Schilder CM; van der Wall E; Meershoek-Klein Kranenbarg E; van de Velde CJH; Schagen SB
    JNCI Cancer Spectr; 2023 Mar; 7(2):. PubMed ID: 37004168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen-related endocrine symptoms in Chinese patients with breast cancer: Study protocol clinical trial (SPIRIT Compliant).
    Chan CWH; Miaskowski C; McCarthy A; Waye MMY; Yeo W; So WKW; Choi KC; Tsui SKW; Chan JYW
    Medicine (Baltimore); 2020 Feb; 99(8):e19083. PubMed ID: 32080081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principles and indications of endocrine treatment of advanced breast cancer.
    Mouridsen HT; Palshof T
    Recent Results Cancer Res; 1980; 71():112-7. PubMed ID: 7367722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-Related Cognitive Impairment in Patients With a History of Breast Cancer.
    Van Dyk K; Ganz PA
    JAMA; 2021 Nov; 326(17):1736-1737. PubMed ID: 34652424
    [No Abstract]   [Full Text] [Related]  

  • 15. Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: cochrane review.
    Hind D; Wyld L; Reed MW
    Br J Cancer; 2007 Apr; 96(7):1025-9. PubMed ID: 17285133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.
    Atakpa EC; Thorat MA; Cuzick J; Brentnall AR
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013091. PubMed ID: 34697802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between endocrine therapy use and dementia among post-menopausal women treated for early-stage breast cancer in Ontario, Canada.
    Blanchette PS; Lam M; Le B; Richard L; Shariff SZ; Pritchard KI; Raphael J; Vandenberg T; Fernandes R; Desautels D; Chan KKW; Earle CC
    J Geriatr Oncol; 2020 Sep; 11(7):1132-1137. PubMed ID: 32611495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Goel S; Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD004562. PubMed ID: 19821328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: a prospective randomized study.
    Berglund G; Nystedt M; Bolund C; Sjödén PO; Rutquist LE
    J Clin Oncol; 2001 Jun; 19(11):2788-96. PubMed ID: 11387349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The post-treatment cognitive impairment ("chemobrain") in breast cancer patients. Short review.].
    Nagykálnai T; Landherr L
    Magy Onkol; 2017 Dec; 61(4):349-351. PubMed ID: 29257154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.